These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8821311)

  • 21. Treatment of severe mania with intravenous magnesium sulphate as a supplementary therapy.
    Heiden A; Frey R; Presslich O; Blasbichler T; Smetana R; Kasper S
    Psychiatry Res; 1999 Dec; 89(3):239-46. PubMed ID: 10708270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mood stabilizer loading versus titration in acute mania: audit of clinical practice.
    Wheeler A; Robinson G; Fraser A
    Aust N Z J Psychiatry; 2008 Nov; 42(11):955-62. PubMed ID: 18941960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lower serum levels of lithium may produce efficacy without adverse effects.
    Shim SS
    Am J Geriatr Psychiatry; 2009 Jul; 17(7):625; author reply 625-6. PubMed ID: 19546659
    [No Abstract]   [Full Text] [Related]  

  • 24. Selection of initial treatment for bipolar disorder, manic phase.
    Frye MA; Altshuler LL
    Mod Probl Pharmacopsychiatry; 1997; 25():88-113. PubMed ID: 9344372
    [No Abstract]   [Full Text] [Related]  

  • 25. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
    Maina G; Albert U; Salvi V; Mancini M; Bogetto F
    J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lithium for prepubertal depressed children with family history predictors of future bipolarity: a double-blind, placebo-controlled study.
    Geller B; Cooper TB; Zimerman B; Frazier J; Williams M; Heath J; Warner K
    J Affect Disord; 1998 Nov; 51(2):165-75. PubMed ID: 10743849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A simpler and more accurate equation to predict daily lithium dose.
    Terao T; Okuno K; Okuno T; Nakano H; Shinkai T; Ohmori O; Yoshimura R; Suzuki T; Abe K
    J Clin Psychopharmacol; 1999 Aug; 19(4):336-40. PubMed ID: 10440461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreasing requirement for lithium carbonate therapy in bipolar affective disorders (hypomanic type) following the onset of chronic renal insufficiency.
    Pandita-Gunawardena R; Donaldson D
    J R Soc Health; 1998 Feb; 118(1):35-9. PubMed ID: 9724937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.
    Goodwin GM; Bowden CL; Calabrese JR; Grunze H; Kasper S; White R; Greene P; Leadbetter R
    J Clin Psychiatry; 2004 Mar; 65(3):432-41. PubMed ID: 15096085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
    Amsterdam JD; Shults J
    J Affect Disord; 2009 May; 115(1-2):234-40. PubMed ID: 18694599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium.
    Nierenberg AA; Friedman ES; Bowden CL; Sylvia LG; Thase ME; Ketter T; Ostacher MJ; Leon AC; Reilly-Harrington N; Iosifescu DV; Pencina M; Severe JB; Calabrese JR
    Am J Psychiatry; 2013 Jan; 170(1):102-10. PubMed ID: 23288387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic efficacy of lithium administered every second day: a WHO multicentre study.
    Plenge P; Amin M; Agarwal AK; Greil W; Kim MJ; Panteleyeva G; Park JM; Prilipko L; Rayushkin V; Sharma M; Mellerup E
    Bipolar Disord; 1999 Dec; 1(2):109-16. PubMed ID: 11252657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two cases of bipolar disorder successfully stabilized for five years with a low dose of risperidone and lithium.
    Yoshimura R; Ueda N; Shinkai K; Nakamura J
    Pharmacopsychiatry; 2006 Nov; 39(6):233-4. PubMed ID: 17124648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Algorithms for the pharmacotherapy of bipolar disorder.
    Motohashi N
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S41-4. PubMed ID: 10560897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient aphasia associated with lithium intoxication.
    Gordon PH; Hirsch LJ; Balmaceda C
    J Clin Psychopharmacol; 1997 Feb; 17(1):55-6. PubMed ID: 9004059
    [No Abstract]   [Full Text] [Related]  

  • 36. Rapid versus non-rapid cycling bipolar II depression: response to venlafaxine and lithium and hypomanic risk.
    Lorenzo-Luaces L; Amsterdam JD; Soeller I; DeRubeis RJ
    Acta Psychiatr Scand; 2016 Jun; 133(6):459-69. PubMed ID: 26803764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reliability and validity of the Korean version of UKU-SERS-Pat in patients with bipolar disorder.
    Kim JH; Choi SW; Joe SH; Ha TH; Yoo HJ; Choi JE; Cha B; Ha K
    Nord J Psychiatry; 2008; 62(6):496-502. PubMed ID: 18841509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
    Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.
    Bowden CL; Mosolov S; Hranov L; Chen E; Habil H; Kongsakon R; Manfredi R; Lin HN
    Int Clin Psychopharmacol; 2010 Mar; 25(2):60-7. PubMed ID: 20101186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inter-episodic morbidity and drop-out under carbamazepine and lithium in the maintenance treatment of bipolar disorder.
    Kleindienst N; Greil W
    Psychol Med; 2002 Apr; 32(3):493-501. PubMed ID: 11989994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.